Metal-polyphenol nanomedicines for malignant tumor therapy

Area of Science:

• Nanomedicine
• Oncology
• Materials Science

Background:

• Malignant tumors remain a critical clinical challenge, necessitating novel therapeutic strategies beyond current options.
• Existing treatments like surgery, chemoradiotherapy, targeted therapy, and immunotherapy have limitations, driving the need for improved drug efficacy and reduced toxicity.
• Nanomedicine presents a promising avenue for advancing cancer treatment modalities.

Purpose of the Study:

• To systematically review the advantages and mechanisms of metal-polyphenol nanomaterials in cancer therapy.
• To dissect the antitumor mechanisms of polyphenols within these nanomaterials.
• To outline the potential of complex metal-polyphenol nanomaterials for treating malignancies.

Main Methods:

• Categorization of metal-polyphenol systems based on metal species.
• Analysis of polyphenol antitumor mechanisms.
• Review of engineered nanostructures (nanodots, nanospheres, network structures) for drug delivery and synergistic therapies.

Main Results:

• Metal-polyphenol nanomaterials can encapsulate therapeutic agents for precision therapy via passive and active targeting.
• These nanocomposites integrate functionalities like chemodynamic therapy, photothermal therapy, and photodynamic therapy for amplified antitumor effects.
• Current research is dominated by limited polyphenol types (curcumin, tannic acid, epigallocatechin gallate), with a scarcity of complex metal-polyphenol nanomaterials.

Conclusions:

• Metal-polyphenol nanomaterials demonstrate significant potential for treating malignancies due to their versatile engineering and synergistic therapeutic capabilities.
• Further research into complex metal-polyphenol nanomaterials is warranted to expand their application in oncology.
• These advanced materials offer a promising future for enhanced cancer treatment with improved efficacy and targeted delivery.